![logo](/logos/ACST.webp)
Acasti Pharma Inc.
NASDAQ:ACST
2.41 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Acasti Pharma Inc. |
Symbool | ACST |
Munteenheid | USD |
Prijs | 2.41 |
Beurswaarde | 24,437,159 |
Dividendpercentage | 0% |
52-weken bereik | 1.72 - 3.59 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Prashant Kohli |
Website | https://www.acastipharma.com |
An error occurred while fetching data.
Over Acasti Pharma Inc.
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)